(Q34159377)

31 July 2017

1 reference

title

A review of available fibrin-specific thrombolytic agents used in acute myocardial infarction (English)

1 reference

31 July 2017

1 reference

myocardial infarction

1 reference

J P Tsikouris

1

1 reference

31 July 2017

A P Tsikouris

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

21

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

207-217

1 reference

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

Coronary thrombosis: pathogenesis and clinical manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

Effect of reteplase on hemostasis variables: analysis of fibrin specificity, relation to bleeding complications and coronary patency

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

A faster-acting and more potent form of tissue plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

Serpin-resistant mutants of human tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

A comparison of reteplase with alteplase for acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.2.207.34103

10.1592/PHCO.21.2.207.34103

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference